Bluebird bio to present additional long-term follow-up data from gene therapy programs in sickle cell disease and beta-thalassemia at the 66th american society of hematology (ash) annual meeting and exposition

Somerville, mass.--(business wire)--bluebird bio presenting data from gene therapy programs in sickle cell disease and beta-thalassemia at the 66th ash annual meeting and exposition.
ASH Ratings Summary
ASH Quant Ranking